Pepticon Advance

Remeco PEPTICON Advance Oral Suspension is an opaque, almost white and peppermint odour viscous suspension.
Each 10 mL of suspension contains 1,000 mg sodium alginate and 200 mg potassium bicarbonate.

Pharmacology: Pharmacodynamics: Remeco PEPTICON Advance Oral Suspension relieves the pain & discomfort of heartburn and acid indigestion by forming a protective layer on top of the stomach contents to prevent stomach acid escaping up into the food pipe where it hurts.
Pharmacokinetics: Absorption: The mechanism of action of the medicinal product is physical and does not depend on absorption into the systemic circulation.
Distribution: No data available.
Biotransformation: No data available.
Elimination: No data available.
Linear/Non-linear situation: No data available.

Treatment of symptoms resulting from the reflux of acid into the oesophagus such as acid regurgitation, heartburn and indigestion which, for example, can occur after meals or during pregnancy.

For oral use.
Shake well before use.
Adults, including elderly and children over 12 years: Take 5-10 mL (one to two 5 mL spoonfuls) after meals and at bedtime.
Children under 12 years: Not to be given unless recommended by the doctor.

In the event of overdose, symptomatic treatment should be given. The patient may notice abdominal distension.

Remeco PEPTICON Advance Oral Suspension is contraindicated in patients with known or suspected hypersensitivity to the active substances or to any of the excipients, including hydroxybenzoate esters (parabens).

Each 10 mL dose has a sodium content of 125.5 mg and a potassium content of 78 mg. This should be taken into account when a highly restricted salt diet is recommended, e.g. in some cases of congestive cardiac failure and renal impairment or when taking drugs which can increase plasma potassium levels.
Each 10 mL contains 200 mg of calcium carbonate. Care needs to be taken intreating patients with hypercalcaemia, nephrocalcinosis and recurrent calcium renal calculi.
This medicinal product contains Methyl paraben (E 218) and Propyl paraben (E 216), which may cause allergic reactions (possibly delayed).
If symptoms do not improve after seven days, the clinical situation of patient should be reviewed by doctor. Patients should avoid using more than they need.
Do not use PEPTICON in following situations: Patients with severe/partial renal function/failure; Hypophosphatemic patients.
It is possible for this medicine to reduction in activity for the patient who has very low gastric acid levels.
Children with renal failure or gastroenteritis are under a serious hypernatremia risk.
Except medical advice, it is generally not recommended in the treatment of children under 12 years.
Effects on ability to drive and use machine: It has no effect on ability to drive and use machines.

Women of childbearing potential/birth control (contraception): No data that proposes additional contraceptive method while treatment. There is no evidence that the effects on contraception methods.
Pregnancy: Clinical studies and post-marketing experience on more than 500 pregnant women have shown that the active substances have no effect on the fetus/newborn poisoning or deformity. When clinically necessary, Remeco PEPTICON Advance Oral Suspension can be used during pregnancy.
Breast feeding: No known effect on breast fed infants. Remeco PEPTICON Advance Oral Suspension can be used during breast feeding.
Fertility: No known effect on human fertility.

Adverse reactions have been ranked under headings of frequency using the following convention: very common (1/10), common (<1/10 and ≥1/100), uncommon (<1/100 and ≥1/1,000), rare (<1/1,000 and ≥1/10,000), very rare (<1/10,000) and not known (cannot be estimated from the available data).
Immune System Disorders: Very rare: Anaphylactic and anaphylactoid reactions, hypersensitivity reactions such as urticaria.
Metabolism and Nutrition Disorders: Not known: Excess amount of calcium carbonate consumption can cause alkalosis, hypercalcemia, acid rebound, milk alkali syndrome or constipation.
Generally, these side effects can occur when taken more than normal dose.
Respiratory, Thoracic and Mediastinal Disorders: Very rare: Respiratory effects such as bronchospasm.
Gastrointestinal Disorders: Not known: Constipation.

A time-interval of 2 hours should be considered between Remeco PEPTICON Advance Oral Suspension intake and the administration of other medicinal products, especially tetracyclines, fluoroquinolones, iron salts, thyroid hormones, chloroquine, bisphosphonates, and estramustine.

Store below 30°C. Do not refrigerate or freeze. Check that the cap seal is unbroken before first taking this product.
Use within 6 months after first opening.

Antacids, Antireflux Agents & Antiulcerants

A02BX13 - alginic acid ; Belongs to the class of other drugs used in the treatment of peptic ulcer and gastro-oesophageal reflux disease (GERD).

NP